We have located links that may give you full text access.
Contrast-Enhanced Harmonic Endoscopic Ultrasound-Guided Fine-Needle Aspiration versus Standard Fine-Needle Aspiration in Pancreatic Masses: A Propensity Score Analysis.
Diagnostics 2020 October 7
BACKGROUND: Whether endoscopic ultrasound (EUS) contrast-enhanced fine-needle aspiration (CH-EUS-FNA) determines superior results in comparison to standard EUS-FNA in tissue acquisition of pancreatic masses remains unclear. The aim of this study was to compare these two techniques on a series of patients with solid pancreatic lesions.
METHODS: 362 patients underwent EUS-FNA (2008-2019), after the propensity score matching of two groups were compared; 103 treated with CH-EUS-FNA (group 1) and 103 with standard EUS-FNA (group 2). The primary outcome was the diagnostic accuracy. Secondary outcomes were sensitivity, specificity, and sample adequacy.
RESULTS: Diagnostic sensitivity was 87.6% in group 1 and 80% in group 2 ( p = 0.18). The negative predictive value was 56% in group 1 and 41.5% in group 2 ( p = 0.06). The specificity and positive predictive values were 100% for both groups. Diagnostic accuracy was 89.3% and 82.5%, respectively ( p = 0.40). Sample adequacy was 94.1% in group 1 and 91.2% in group 2 ( p = 0.42). The rate of adequate core histologic samples was 33% and 28.1%, respectively ( p = 0.44), and the number of needle passes to obtain adequate samples were 2.4 ± 0.6 and 2.7 ± 0.8, respectively ( p = 0.76). These findings were confirmed in subgroup analyses, conducted according to lesion size and contrast enhancement pattern.
CONCLUSIONS: CH-EUS-FNA does not appear to be superior to standard EUS-FNA in patients with pancreatic masses.
METHODS: 362 patients underwent EUS-FNA (2008-2019), after the propensity score matching of two groups were compared; 103 treated with CH-EUS-FNA (group 1) and 103 with standard EUS-FNA (group 2). The primary outcome was the diagnostic accuracy. Secondary outcomes were sensitivity, specificity, and sample adequacy.
RESULTS: Diagnostic sensitivity was 87.6% in group 1 and 80% in group 2 ( p = 0.18). The negative predictive value was 56% in group 1 and 41.5% in group 2 ( p = 0.06). The specificity and positive predictive values were 100% for both groups. Diagnostic accuracy was 89.3% and 82.5%, respectively ( p = 0.40). Sample adequacy was 94.1% in group 1 and 91.2% in group 2 ( p = 0.42). The rate of adequate core histologic samples was 33% and 28.1%, respectively ( p = 0.44), and the number of needle passes to obtain adequate samples were 2.4 ± 0.6 and 2.7 ± 0.8, respectively ( p = 0.76). These findings were confirmed in subgroup analyses, conducted according to lesion size and contrast enhancement pattern.
CONCLUSIONS: CH-EUS-FNA does not appear to be superior to standard EUS-FNA in patients with pancreatic masses.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app